Author: Bella Hayes

LONDON – Pennpetro Energy PLC (LSE: PPP) has announced its plan to place up to 8 million shares through a managed tender process by Peterhouse Capital. The auction will open today and is set to close at 5 pm on January 7, 2025. This move follows a recent capital raise of £120,000 on November 27, 2024, where shares were issued at a premium. The tender process, labeled “The Placing,” is targeting sophisticated and professional investors, setting a minimum bid price of 9.0p per share. Retail investors are also invited to participate through their agents or brokers. The shares will only…

Read More

Hong Kong, Dec. 30, 2024 (GLOBE NEWSWIRE) — Garden Stage Limited (NASDAQ: GSIW) (GSIW or the Company), today announced that it received a delinquency notification letter (the Notice) from the Listing Qualifications Department of The Stock Market LLC (Nasdaq) on December 24, 2024 indicating that the Company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq’s Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the Company’s ordinary shares listed on the Nasdaq Capital Market was below $1.00 per share for 30 consecutive business days. Nasdaq Listing…

Read More

SUZHOU, China, Dec. 30, 2024 /PRNewswire/ — Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as “Huadong Medicine”), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as “SynerK”) have reached a strategic cooperation. The two parties will jointly develop the small nucleic acid (siRNA) drug SNK-2726, targeting angiotensinogen (AGT) for the treatment of hypertension. Huadong Medicine has obtained the exclusive option, once exercised, for the right to develop, register, manufacture and commercialize the drug in Greater China.   SynerK owns intellectual property rights of SNK-2726, which is currently in…

Read More

New York, New York–(Newsfile Corp. – December 30, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: NASDAQ:) between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased WBD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the WBD class action, go to https://rosenlegal.com/submit-form/?case_id=31683 or…

Read More

New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: LON:) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rentokil class action, go to…

Read More

New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call…

Read More

Luke Hans, the Company’s latest Developer Co-Creation Officer, will receive his FF 91 2.0 Futurist Alliance during a delivery ceremony next month in Los Angeles with Company executives. LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (Faraday Future, FF, or Company), a California-based global shared intelligent electric mobility ecosystem company, today announced that Luke Hans, a prominent entrepreneur and leader in the Los Angeles Chinese community, will take delivery of his new FF 91 2.0 Futurist Alliance EV in January 2025 during a delivery ceremony with FF executives. This will mark the first delivery of an FF 91 2.0…

Read More

New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ: LON:) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 21, 2025 in the securities class action first filed by the Firm. SO WHAT: If you purchased AstraZeneca (NASDAQ:) securities during the Class…

Read More

New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox (NASDAQ:) Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Xerox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Xerox class action, go to https://rosenlegal.com/submit-form/?case_id=31433 or…

Read More

Philadelphia, Pennsylvania–(Newsfile Corp. – December 29, 2024) – A securities class action lawsuit has been filed against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS). The lawsuit has been filed on behalf of purchasers of PACS securities between April 8, 2024 and November 21, 2024, inclusive (the “Class Period”).CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired PACS securities during the Class Period may, no later than JANUARY 13, 2025, seek to be appointed as a lead plaintiff representative of the class. Headquartered in Farmington, Utah, PACS operates skilled nursing facilities and post-acute care facilities…

Read More